BPC157 + TB500 10MG

What is BPC-157 / TB-500?

BPC-157 / TB-500 (also written BPC157 TB500) is a synergistic two-peptide formulation engineered for advanced laboratory research. It combines BPC-157, a synthetic fragment derived from a naturally occurring body-protection compound, with TB-500, a synthetic version of the thymosin β-4 fragment known for its role in cellular structure and mobility. Together, these peptides are widely studied for their influence on cellular repair, tissue organisation, and actin regulation in controlled scientific environments. Lazarus Labs supplies this dual-peptide blend in Australia in a pharmaceutical-grade lyophilised form, delivering verified purity and consistency for reproducible results.

Why researchers choose Lazarus Labs

Each vial is produced in a GMP-compliant, ISO-certified facility and validated through independent HPLC and LC-MS analysis, with a certificate of analysis available for every batch. Every batch meets or exceeds ≥ 99 % verified purity and is tested for identity, solubility, and molecular integrity. Lazarus Labs’ rigorous standards ensure that researchers across Australia receive dependable compounds suitable for high-precision experimental work.

Product highlights

• Total Concentration: 10 mg per vial
• Composition: BPC-157 (5 mg) + TB-500 (5 mg)
• Purity: ≥ 99 % (independently verified)
• Solubility: Fully soluble in water (H₂O)
• Manufacturing: GMP + ISO 9001:2008 compliant
• Use: Designed for tissue, actin, and cellular-response research

Handling & storage

Keep sealed and stored dry at 2–8 °C. Follow your internal laboratory handling and stability procedures after preparation.

For in-vitro research and laboratory use only · Not for human or animal consumption · Not a therapeutic good · 18+